156 related articles for article (PubMed ID: 715455)
1. beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa).
Margules DL; Moisset B; Lewis MJ; Shibuya H; Pert CB
Science; 1978 Dec; 202(4371):988-91. PubMed ID: 715455
[TBL] [Abstract][Full Text] [Related]
2. Studies on the role of opiate peptides in two forms of genetic obesity: ob/ob mouse and fa/fa rat.
Recant L; Voyles N; Wade A; Awoke S; Bhathena SJ
Horm Metab Res; 1983 Dec; 15(12):589-93. PubMed ID: 6363242
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
Recant L; Voyles NR; Luciano M; Pert CB
Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
[TBL] [Abstract][Full Text] [Related]
4. Absence of naloxone sensitivity in obese humans.
O'Brien CP; Stunkard AJ; Ternes JW
Psychosom Med; 1982 May; 44(2):215-23. PubMed ID: 6283579
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of diazepam-induced feeding in rats by antisera to opioid peptides.
González Y; Fernández-Tomé MP; Sánchez-Franco F; del Río J
Life Sci; 1984 Sep; 35(13):1423-9. PubMed ID: 6090835
[TBL] [Abstract][Full Text] [Related]
6. Altered beta-endorphin, Met- and Leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome.
Timmers K; Voyles NR; Zalenski C; Wilkins S; Recant L
Diabetes; 1986 Oct; 35(10):1143-51. PubMed ID: 2944783
[TBL] [Abstract][Full Text] [Related]
7. Pituitary beta-endorphin, naloxone, and feeding in several experimental obesities.
Gunion MW; Peters RH
Am J Physiol; 1981 Sep; 241(3):R173-84. PubMed ID: 6269442
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunization against beta-endorphin increases food intakes and body weights of obese rats.
McLaughlin CL; Baile CA
Physiol Behav; 1985 Sep; 35(3):365-70. PubMed ID: 2933753
[TBL] [Abstract][Full Text] [Related]
9. Central mu, delta, and kappa opioid binding sites, and brain and pituitary beta-endorphin and met-enkephalin in genetically obese (ob/ob) and lean mice.
Khawaja XZ; Bailey CJ; Green IC
Life Sci; 1989; 44(16):1097-105. PubMed ID: 2523015
[TBL] [Abstract][Full Text] [Related]
10. The obesity of middle age: a common variety of Cushing's syndrome due to a chronic increase in adrenocorticotrophin (ACTH) and beta-endorphin activity.
Margules DL
Adv Exp Med Biol; 1979; 116():279-90. PubMed ID: 224674
[TBL] [Abstract][Full Text] [Related]
11. Meal-stimulated increased concentrations of beta-endorphin in the hypothalamus of Zucker obese and lean rats.
McLaughlin CL; Baile CA; Della-Fera MA
Physiol Behav; 1985 Dec; 35(6):891-6. PubMed ID: 2937072
[TBL] [Abstract][Full Text] [Related]
12. Anti-opiate (naloxone) suppression of Cushingoid degenerative changes in obese/SHR.
Wexler BC; McMurtry JP
Int J Obes; 1985; 9(2):77-91. PubMed ID: 2993179
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactive beta-endorphin and met- and leu-enkephalin contents in pancreas and pituitary of corpulent (cp/cp) rats.
Timmers K; Voyles NR; Wilkins S; Michaelis OE; Bhathena SJ; Recant L
Int J Obes; 1989; 13(3):337-45. PubMed ID: 2527831
[TBL] [Abstract][Full Text] [Related]
14. Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development.
Rossier J; Rogers J; Shibasaki T; Guillemin R; Bloom FE
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2077-80. PubMed ID: 287046
[TBL] [Abstract][Full Text] [Related]
15. Stress-induced release of brain and pituitary beta-endorphin: major role of endorphins in generation of hyperthermia, not analgesia.
Millan MJ; Przewłocki R; Jerlicz M; Gramsch C; Höllt V; Herz A
Brain Res; 1981 Mar; 208(2):325-38. PubMed ID: 6260287
[TBL] [Abstract][Full Text] [Related]
16. beta-Endorphin and beta-lipotropin plasma levels in hirsute women: correlation with body weight.
Givens JR; Wiedemann E; Andersen RN; Kitabchi AE
J Clin Endocrinol Metab; 1980 May; 50(5):975-6. PubMed ID: 6445374
[TBL] [Abstract][Full Text] [Related]
17. Functional aspects of endorphins.
Herz A; Höllt V; Przewłocki R; Osborne H; Gramsch C; Duka T
Prog Biochem Pharmacol; 1980; 16():11-21. PubMed ID: 7443728
[TBL] [Abstract][Full Text] [Related]
18. Plasma B-cell tropin (ACTH22-39) concentration in lean and obese (ob/ob) mice and lean and obese (fa/fa) Zucker rats.
Morton JL; Davenport M; Dunmore SJ
Biochem Biophys Res Commun; 1991 Jan; 174(2):767-71. PubMed ID: 1847053
[TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
Sarkar DK; Yen SS
Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
[TBL] [Abstract][Full Text] [Related]
20. beta-endorphin-(1-27) is an antagonist of beta-endorphin analgesia.
Hammonds RG; Nicolas P; Li CH
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1389-90. PubMed ID: 6324189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
